Antibiofilm activity of an exopolysaccharide from marine bacterium Vibrio sp. QY101
Bacterial exopolysaccharides have always been suggested to play crucial roles in the bacterial initial adhesion and the development of complex architecture in the later stages of bacterial biofilm formation. However, Escherichia coli group II capsular polysaccharide was characterized to exert broad-...
Gespeichert in:
Veröffentlicht in: | PloS one 2011-04, Vol.6 (4), p.e18514 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | 4 |
container_start_page | e18514 |
container_title | PloS one |
container_volume | 6 |
creator | Jiang, Peng Li, Jingbao Han, Feng Duan, Gaofei Lu, Xinzhi Gu, Yuchao Yu, Wengong |
description | Bacterial exopolysaccharides have always been suggested to play crucial roles in the bacterial initial adhesion and the development of complex architecture in the later stages of bacterial biofilm formation. However, Escherichia coli group II capsular polysaccharide was characterized to exert broad-spectrum biofilm inhibition activity. In this study, we firstly reported that a bacterial exopolysaccharide (A101) not only inhibits biofilm formation of many bacteria but also disrupts established biofilm of some strains. A101 with an average molecular weight of up to 546 KDa, was isolated and purified from the culture supernatant of the marine bacterium Vibrio sp. QY101 by ethanol precipitation, iron-exchange chromatography and gel filtration chromatography. High performance liquid chromatography traces of the hydrolyzed polysaccharides showed that A101 is primarily consisted of galacturonic acid, glucuronic acid, rhamnose and glucosamine. A101 was demonstrated to inhibit biofilm formation by a wide range of Gram-negative and Gram-positive bacteria without antibacterial activity. Furthermore, A101 displayed a significant disruption on the established biofilm produced by Pseudomonas aeruginosa, but not by Staphylococcus aureus. Importantly, A101 increased the aminoglycosides antibiotics' capability of killing P. aeruginosa biofilm. Cell primary attachment to surfaces and intercellular aggregates assays suggested that A101 inhibited cell aggregates of both P. aeruginosa and S. aureus, while the cell-surface interactions inhibition only occurred in S. aureus, and the pre-formed cell aggregates dispersion induced by A101 only occurred in P. aeruginosa. Taken together, these data identify the antibiofilm activity of A101, which may make it potential in the design of new therapeutic strategies for bacterial biofilm-associated infections and limiting biofilm formation on medical indwelling devices. The found of A101 antibiofilm activity may also promote a new recognition about the functions of bacterial exopolysaccharides. |
doi_str_mv | 10.1371/journal.pone.0018514 |
format | Article |
fullrecord | <record><control><sourceid>gale_plos_</sourceid><recordid>TN_cdi_plos_journals_1312182644</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A476898362</galeid><doaj_id>oai_doaj_org_article_1d70866a74d946209d5e2c2258abd7b1</doaj_id><sourcerecordid>A476898362</sourcerecordid><originalsourceid>FETCH-LOGICAL-c789t-1b7b0acb7f7cabb2f8c4944932d59a3aa9e9e19b3971d4a408d29aa48b020dcb3</originalsourceid><addsrcrecordid>eNqNkl2L1DAUhoso7rr6D0QLguLFjPlqm9wIw-LHwMKiqwtehZOPzmRomzFpl51_b8bpLlPZC8lFQvqc95y-ebPsJUZzTCv8YeOH0EEz3_rOzhHCvMDsUXaKBSWzkiD6-Oh8kj2LcYNQQXlZPs1OCGYCCUJPs6tF1zvlfO2aNgfduxvX73Jf59Dl9tZvfbOLoPUagjM2r4Nv8zadO5urRNvghja_dio4n8ftPP_2CyP8PHtSQxPti3E_y35-_vTj_Ovs4vLL8nxxMdMVF_0Mq0oh0KqqKw1KkZprJhhLM5tCAAUQVlgsFBUVNgwY4oYIAMYVIshoRc-y1wfdbeOjHP2IElNMMCclY4lYHgjjYSO3waXZd9KDk38vfFhJCL3TjZXYVCiZAxUzgiXPhCks0YQUHJSpFE5aH8dug2qt0bbrAzQT0emXzq3lyt9IiirCEEkC70aB4H8PNvaydVHbpoHO-iFKzjkSJWFFIt_8Qz78cyO1gjS_62qf2uq9plywquSC03Lfdf4AlZaxrdMpO-nl7bTg_aQgMb297VcwxCiXV9__n728nrJvj9i1haZfR98MvfNdnILsAOrgYwy2vvcYI7mP_p0bch99OUY_lb06fp_7orus0z9wAP2w</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1312182644</pqid></control><display><type>article</type><title>Antibiofilm activity of an exopolysaccharide from marine bacterium Vibrio sp. QY101</title><source>Public Library of Science (PLoS) Journals Open Access</source><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Free Full-Text Journals in Chemistry</source><creator>Jiang, Peng ; Li, Jingbao ; Han, Feng ; Duan, Gaofei ; Lu, Xinzhi ; Gu, Yuchao ; Yu, Wengong</creator><contributor>Hensel, Michael</contributor><creatorcontrib>Jiang, Peng ; Li, Jingbao ; Han, Feng ; Duan, Gaofei ; Lu, Xinzhi ; Gu, Yuchao ; Yu, Wengong ; Hensel, Michael</creatorcontrib><description>Bacterial exopolysaccharides have always been suggested to play crucial roles in the bacterial initial adhesion and the development of complex architecture in the later stages of bacterial biofilm formation. However, Escherichia coli group II capsular polysaccharide was characterized to exert broad-spectrum biofilm inhibition activity. In this study, we firstly reported that a bacterial exopolysaccharide (A101) not only inhibits biofilm formation of many bacteria but also disrupts established biofilm of some strains. A101 with an average molecular weight of up to 546 KDa, was isolated and purified from the culture supernatant of the marine bacterium Vibrio sp. QY101 by ethanol precipitation, iron-exchange chromatography and gel filtration chromatography. High performance liquid chromatography traces of the hydrolyzed polysaccharides showed that A101 is primarily consisted of galacturonic acid, glucuronic acid, rhamnose and glucosamine. A101 was demonstrated to inhibit biofilm formation by a wide range of Gram-negative and Gram-positive bacteria without antibacterial activity. Furthermore, A101 displayed a significant disruption on the established biofilm produced by Pseudomonas aeruginosa, but not by Staphylococcus aureus. Importantly, A101 increased the aminoglycosides antibiotics' capability of killing P. aeruginosa biofilm. Cell primary attachment to surfaces and intercellular aggregates assays suggested that A101 inhibited cell aggregates of both P. aeruginosa and S. aureus, while the cell-surface interactions inhibition only occurred in S. aureus, and the pre-formed cell aggregates dispersion induced by A101 only occurred in P. aeruginosa. Taken together, these data identify the antibiofilm activity of A101, which may make it potential in the design of new therapeutic strategies for bacterial biofilm-associated infections and limiting biofilm formation on medical indwelling devices. The found of A101 antibiofilm activity may also promote a new recognition about the functions of bacterial exopolysaccharides.</description><identifier>ISSN: 1932-6203</identifier><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0018514</identifier><identifier>PMID: 21490923</identifier><language>eng</language><publisher>United States: Public Library of Science</publisher><subject>Acids ; Aggregates ; Aminoglycosides ; Anti-Bacterial Agents - pharmacology ; Antibacterial activity ; Antibiotics ; Apoptosis ; Bacteria ; Biofilms ; Biofilms - drug effects ; Biology ; Cell culture ; Cell surface ; Chromatography ; Chromatography, High Pressure Liquid ; Disruption ; Drug dosages ; Drug resistance ; E coli ; Education ; Enterococcus faecalis ; Escherichia coli ; Ethanol ; Exopolysaccharides ; Gel filtration ; Glucosamine ; Gram-positive bacteria ; High performance liquid chromatography ; Inhibition ; Iron ; Killing ; Laboratories ; Liquid chromatography ; Marine ; Medical electronics ; Medicine ; Molecular weight ; Motility ; Pathogens ; Pharmacy ; Polysaccharides ; Polysaccharides, Bacterial - pharmacology ; Proteins ; Pseudomonas aeruginosa ; Pseudomonas aeruginosa - drug effects ; Pseudomonas aeruginosa - growth & development ; Rhamnose ; Saccharides ; Spectroscopy, Fourier Transform Infrared ; Staphylococcus aureus ; Staphylococcus aureus - drug effects ; Staphylococcus aureus - growth & development ; Vibrio ; Vibrio - chemistry ; Water-borne diseases ; Waterborne diseases</subject><ispartof>PloS one, 2011-04, Vol.6 (4), p.e18514</ispartof><rights>COPYRIGHT 2011 Public Library of Science</rights><rights>2011 Jiang et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License: https://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>Jiang et al. 2011</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c789t-1b7b0acb7f7cabb2f8c4944932d59a3aa9e9e19b3971d4a408d29aa48b020dcb3</citedby><cites>FETCH-LOGICAL-c789t-1b7b0acb7f7cabb2f8c4944932d59a3aa9e9e19b3971d4a408d29aa48b020dcb3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3072402/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3072402/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,2096,2915,23845,27901,27902,53766,53768,79343,79344</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21490923$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Hensel, Michael</contributor><creatorcontrib>Jiang, Peng</creatorcontrib><creatorcontrib>Li, Jingbao</creatorcontrib><creatorcontrib>Han, Feng</creatorcontrib><creatorcontrib>Duan, Gaofei</creatorcontrib><creatorcontrib>Lu, Xinzhi</creatorcontrib><creatorcontrib>Gu, Yuchao</creatorcontrib><creatorcontrib>Yu, Wengong</creatorcontrib><title>Antibiofilm activity of an exopolysaccharide from marine bacterium Vibrio sp. QY101</title><title>PloS one</title><addtitle>PLoS One</addtitle><description>Bacterial exopolysaccharides have always been suggested to play crucial roles in the bacterial initial adhesion and the development of complex architecture in the later stages of bacterial biofilm formation. However, Escherichia coli group II capsular polysaccharide was characterized to exert broad-spectrum biofilm inhibition activity. In this study, we firstly reported that a bacterial exopolysaccharide (A101) not only inhibits biofilm formation of many bacteria but also disrupts established biofilm of some strains. A101 with an average molecular weight of up to 546 KDa, was isolated and purified from the culture supernatant of the marine bacterium Vibrio sp. QY101 by ethanol precipitation, iron-exchange chromatography and gel filtration chromatography. High performance liquid chromatography traces of the hydrolyzed polysaccharides showed that A101 is primarily consisted of galacturonic acid, glucuronic acid, rhamnose and glucosamine. A101 was demonstrated to inhibit biofilm formation by a wide range of Gram-negative and Gram-positive bacteria without antibacterial activity. Furthermore, A101 displayed a significant disruption on the established biofilm produced by Pseudomonas aeruginosa, but not by Staphylococcus aureus. Importantly, A101 increased the aminoglycosides antibiotics' capability of killing P. aeruginosa biofilm. Cell primary attachment to surfaces and intercellular aggregates assays suggested that A101 inhibited cell aggregates of both P. aeruginosa and S. aureus, while the cell-surface interactions inhibition only occurred in S. aureus, and the pre-formed cell aggregates dispersion induced by A101 only occurred in P. aeruginosa. Taken together, these data identify the antibiofilm activity of A101, which may make it potential in the design of new therapeutic strategies for bacterial biofilm-associated infections and limiting biofilm formation on medical indwelling devices. The found of A101 antibiofilm activity may also promote a new recognition about the functions of bacterial exopolysaccharides.</description><subject>Acids</subject><subject>Aggregates</subject><subject>Aminoglycosides</subject><subject>Anti-Bacterial Agents - pharmacology</subject><subject>Antibacterial activity</subject><subject>Antibiotics</subject><subject>Apoptosis</subject><subject>Bacteria</subject><subject>Biofilms</subject><subject>Biofilms - drug effects</subject><subject>Biology</subject><subject>Cell culture</subject><subject>Cell surface</subject><subject>Chromatography</subject><subject>Chromatography, High Pressure Liquid</subject><subject>Disruption</subject><subject>Drug dosages</subject><subject>Drug resistance</subject><subject>E coli</subject><subject>Education</subject><subject>Enterococcus faecalis</subject><subject>Escherichia coli</subject><subject>Ethanol</subject><subject>Exopolysaccharides</subject><subject>Gel filtration</subject><subject>Glucosamine</subject><subject>Gram-positive bacteria</subject><subject>High performance liquid chromatography</subject><subject>Inhibition</subject><subject>Iron</subject><subject>Killing</subject><subject>Laboratories</subject><subject>Liquid chromatography</subject><subject>Marine</subject><subject>Medical electronics</subject><subject>Medicine</subject><subject>Molecular weight</subject><subject>Motility</subject><subject>Pathogens</subject><subject>Pharmacy</subject><subject>Polysaccharides</subject><subject>Polysaccharides, Bacterial - pharmacology</subject><subject>Proteins</subject><subject>Pseudomonas aeruginosa</subject><subject>Pseudomonas aeruginosa - drug effects</subject><subject>Pseudomonas aeruginosa - growth & development</subject><subject>Rhamnose</subject><subject>Saccharides</subject><subject>Spectroscopy, Fourier Transform Infrared</subject><subject>Staphylococcus aureus</subject><subject>Staphylococcus aureus - drug effects</subject><subject>Staphylococcus aureus - growth & development</subject><subject>Vibrio</subject><subject>Vibrio - chemistry</subject><subject>Water-borne diseases</subject><subject>Waterborne diseases</subject><issn>1932-6203</issn><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><sourceid>DOA</sourceid><recordid>eNqNkl2L1DAUhoso7rr6D0QLguLFjPlqm9wIw-LHwMKiqwtehZOPzmRomzFpl51_b8bpLlPZC8lFQvqc95y-ebPsJUZzTCv8YeOH0EEz3_rOzhHCvMDsUXaKBSWzkiD6-Oh8kj2LcYNQQXlZPs1OCGYCCUJPs6tF1zvlfO2aNgfduxvX73Jf59Dl9tZvfbOLoPUagjM2r4Nv8zadO5urRNvghja_dio4n8ftPP_2CyP8PHtSQxPti3E_y35-_vTj_Ovs4vLL8nxxMdMVF_0Mq0oh0KqqKw1KkZprJhhLM5tCAAUQVlgsFBUVNgwY4oYIAMYVIshoRc-y1wfdbeOjHP2IElNMMCclY4lYHgjjYSO3waXZd9KDk38vfFhJCL3TjZXYVCiZAxUzgiXPhCks0YQUHJSpFE5aH8dug2qt0bbrAzQT0emXzq3lyt9IiirCEEkC70aB4H8PNvaydVHbpoHO-iFKzjkSJWFFIt_8Qz78cyO1gjS_62qf2uq9plywquSC03Lfdf4AlZaxrdMpO-nl7bTg_aQgMb297VcwxCiXV9__n728nrJvj9i1haZfR98MvfNdnILsAOrgYwy2vvcYI7mP_p0bch99OUY_lb06fp_7orus0z9wAP2w</recordid><startdate>20110407</startdate><enddate>20110407</enddate><creator>Jiang, Peng</creator><creator>Li, Jingbao</creator><creator>Han, Feng</creator><creator>Duan, Gaofei</creator><creator>Lu, Xinzhi</creator><creator>Gu, Yuchao</creator><creator>Yu, Wengong</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IOV</scope><scope>ISR</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QO</scope><scope>7RV</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TG</scope><scope>7TM</scope><scope>7U9</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>KL.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PATMY</scope><scope>PDBOC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>RC3</scope><scope>7T7</scope><scope>7TN</scope><scope>F1W</scope><scope>H95</scope><scope>H99</scope><scope>L.F</scope><scope>L.G</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20110407</creationdate><title>Antibiofilm activity of an exopolysaccharide from marine bacterium Vibrio sp. QY101</title><author>Jiang, Peng ; Li, Jingbao ; Han, Feng ; Duan, Gaofei ; Lu, Xinzhi ; Gu, Yuchao ; Yu, Wengong</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c789t-1b7b0acb7f7cabb2f8c4944932d59a3aa9e9e19b3971d4a408d29aa48b020dcb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Acids</topic><topic>Aggregates</topic><topic>Aminoglycosides</topic><topic>Anti-Bacterial Agents - pharmacology</topic><topic>Antibacterial activity</topic><topic>Antibiotics</topic><topic>Apoptosis</topic><topic>Bacteria</topic><topic>Biofilms</topic><topic>Biofilms - drug effects</topic><topic>Biology</topic><topic>Cell culture</topic><topic>Cell surface</topic><topic>Chromatography</topic><topic>Chromatography, High Pressure Liquid</topic><topic>Disruption</topic><topic>Drug dosages</topic><topic>Drug resistance</topic><topic>E coli</topic><topic>Education</topic><topic>Enterococcus faecalis</topic><topic>Escherichia coli</topic><topic>Ethanol</topic><topic>Exopolysaccharides</topic><topic>Gel filtration</topic><topic>Glucosamine</topic><topic>Gram-positive bacteria</topic><topic>High performance liquid chromatography</topic><topic>Inhibition</topic><topic>Iron</topic><topic>Killing</topic><topic>Laboratories</topic><topic>Liquid chromatography</topic><topic>Marine</topic><topic>Medical electronics</topic><topic>Medicine</topic><topic>Molecular weight</topic><topic>Motility</topic><topic>Pathogens</topic><topic>Pharmacy</topic><topic>Polysaccharides</topic><topic>Polysaccharides, Bacterial - pharmacology</topic><topic>Proteins</topic><topic>Pseudomonas aeruginosa</topic><topic>Pseudomonas aeruginosa - drug effects</topic><topic>Pseudomonas aeruginosa - growth & development</topic><topic>Rhamnose</topic><topic>Saccharides</topic><topic>Spectroscopy, Fourier Transform Infrared</topic><topic>Staphylococcus aureus</topic><topic>Staphylococcus aureus - drug effects</topic><topic>Staphylococcus aureus - growth & development</topic><topic>Vibrio</topic><topic>Vibrio - chemistry</topic><topic>Water-borne diseases</topic><topic>Waterborne diseases</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jiang, Peng</creatorcontrib><creatorcontrib>Li, Jingbao</creatorcontrib><creatorcontrib>Han, Feng</creatorcontrib><creatorcontrib>Duan, Gaofei</creatorcontrib><creatorcontrib>Lu, Xinzhi</creatorcontrib><creatorcontrib>Gu, Yuchao</creatorcontrib><creatorcontrib>Yu, Wengong</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: Opposing Viewpoints</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Nursing & Allied Health Database</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Meteorological & Geoastrophysical Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Agricultural Science Collection</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science & Engineering Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies & Aerospace Collection</collection><collection>Agricultural & Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Materials Science Database</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Meteorological & Geoastrophysical Abstracts - Academic</collection><collection>ProQuest Engineering Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Agricultural Science Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Engineering Database</collection><collection>Nursing & Allied Health Premium</collection><collection>Advanced Technologies & Aerospace Database</collection><collection>ProQuest Advanced Technologies & Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Materials Science Collection</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Engineering Collection</collection><collection>Environmental Science Collection</collection><collection>Genetics Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Oceanic Abstracts</collection><collection>ASFA: Aquatic Sciences and Fisheries Abstracts</collection><collection>Aquatic Science & Fisheries Abstracts (ASFA) 1: Biological Sciences & Living Resources</collection><collection>ASFA: Marine Biotechnology Abstracts</collection><collection>Aquatic Science & Fisheries Abstracts (ASFA) Marine Biotechnology Abstracts</collection><collection>Aquatic Science & Fisheries Abstracts (ASFA) Professional</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jiang, Peng</au><au>Li, Jingbao</au><au>Han, Feng</au><au>Duan, Gaofei</au><au>Lu, Xinzhi</au><au>Gu, Yuchao</au><au>Yu, Wengong</au><au>Hensel, Michael</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Antibiofilm activity of an exopolysaccharide from marine bacterium Vibrio sp. QY101</atitle><jtitle>PloS one</jtitle><addtitle>PLoS One</addtitle><date>2011-04-07</date><risdate>2011</risdate><volume>6</volume><issue>4</issue><spage>e18514</spage><pages>e18514-</pages><issn>1932-6203</issn><eissn>1932-6203</eissn><abstract>Bacterial exopolysaccharides have always been suggested to play crucial roles in the bacterial initial adhesion and the development of complex architecture in the later stages of bacterial biofilm formation. However, Escherichia coli group II capsular polysaccharide was characterized to exert broad-spectrum biofilm inhibition activity. In this study, we firstly reported that a bacterial exopolysaccharide (A101) not only inhibits biofilm formation of many bacteria but also disrupts established biofilm of some strains. A101 with an average molecular weight of up to 546 KDa, was isolated and purified from the culture supernatant of the marine bacterium Vibrio sp. QY101 by ethanol precipitation, iron-exchange chromatography and gel filtration chromatography. High performance liquid chromatography traces of the hydrolyzed polysaccharides showed that A101 is primarily consisted of galacturonic acid, glucuronic acid, rhamnose and glucosamine. A101 was demonstrated to inhibit biofilm formation by a wide range of Gram-negative and Gram-positive bacteria without antibacterial activity. Furthermore, A101 displayed a significant disruption on the established biofilm produced by Pseudomonas aeruginosa, but not by Staphylococcus aureus. Importantly, A101 increased the aminoglycosides antibiotics' capability of killing P. aeruginosa biofilm. Cell primary attachment to surfaces and intercellular aggregates assays suggested that A101 inhibited cell aggregates of both P. aeruginosa and S. aureus, while the cell-surface interactions inhibition only occurred in S. aureus, and the pre-formed cell aggregates dispersion induced by A101 only occurred in P. aeruginosa. Taken together, these data identify the antibiofilm activity of A101, which may make it potential in the design of new therapeutic strategies for bacterial biofilm-associated infections and limiting biofilm formation on medical indwelling devices. The found of A101 antibiofilm activity may also promote a new recognition about the functions of bacterial exopolysaccharides.</abstract><cop>United States</cop><pub>Public Library of Science</pub><pmid>21490923</pmid><doi>10.1371/journal.pone.0018514</doi><tpages>e18514</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1932-6203 |
ispartof | PloS one, 2011-04, Vol.6 (4), p.e18514 |
issn | 1932-6203 1932-6203 |
language | eng |
recordid | cdi_plos_journals_1312182644 |
source | Public Library of Science (PLoS) Journals Open Access; MEDLINE; DOAJ Directory of Open Access Journals; EZB-FREE-00999 freely available EZB journals; PubMed Central; Free Full-Text Journals in Chemistry |
subjects | Acids Aggregates Aminoglycosides Anti-Bacterial Agents - pharmacology Antibacterial activity Antibiotics Apoptosis Bacteria Biofilms Biofilms - drug effects Biology Cell culture Cell surface Chromatography Chromatography, High Pressure Liquid Disruption Drug dosages Drug resistance E coli Education Enterococcus faecalis Escherichia coli Ethanol Exopolysaccharides Gel filtration Glucosamine Gram-positive bacteria High performance liquid chromatography Inhibition Iron Killing Laboratories Liquid chromatography Marine Medical electronics Medicine Molecular weight Motility Pathogens Pharmacy Polysaccharides Polysaccharides, Bacterial - pharmacology Proteins Pseudomonas aeruginosa Pseudomonas aeruginosa - drug effects Pseudomonas aeruginosa - growth & development Rhamnose Saccharides Spectroscopy, Fourier Transform Infrared Staphylococcus aureus Staphylococcus aureus - drug effects Staphylococcus aureus - growth & development Vibrio Vibrio - chemistry Water-borne diseases Waterborne diseases |
title | Antibiofilm activity of an exopolysaccharide from marine bacterium Vibrio sp. QY101 |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T19%3A27%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Antibiofilm%20activity%20of%20an%20exopolysaccharide%20from%20marine%20bacterium%20Vibrio%20sp.%20QY101&rft.jtitle=PloS%20one&rft.au=Jiang,%20Peng&rft.date=2011-04-07&rft.volume=6&rft.issue=4&rft.spage=e18514&rft.pages=e18514-&rft.issn=1932-6203&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0018514&rft_dat=%3Cgale_plos_%3EA476898362%3C/gale_plos_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1312182644&rft_id=info:pmid/21490923&rft_galeid=A476898362&rft_doaj_id=oai_doaj_org_article_1d70866a74d946209d5e2c2258abd7b1&rfr_iscdi=true |